Short Interest in Ainos, Inc. (NASDAQ:AIMDW) Declines By 52.8%

Ainos, Inc. (NASDAQ:AIMDW) saw a significant decrease in short interest in June. As of June 15th, there was short interest totaling 3,220 shares, a decrease of 52.8% from the May 31st total of 6,829 shares. Based on an average daily volume of 2,622 shares, the short-interest ratio is currently 1.2 days.

Ainos Stock Performance

Shares of AIMDW stock traded up $0.01 on Tuesday, reaching $0.13. 2,820 shares of the company’s stock traded hands, compared to its average volume of 6,089. Ainos has a 12-month low of $0.05 and a 12-month high of $0.95. The business’s 50 day moving average price is $0.10 and its two-hundred day moving average price is $0.11.

About Ainos

Ainos, Inc, a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan.